Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
ROBERT A BERMEL
Listed Specialty: Neurology
9500 EUCLID AVE, BUILDING U10, CLEVELAND, OH, 44195-0001
DR. ROBERT BERMEL,
Yearly Payment Breakdown:
2018 Payments At a Glance
50
payments
$46,051
payment total
8
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Consulting |
10 | $41,334 |
Travel and Lodging |
16 | $3,153 |
Food and Beverage |
24 | $1,564 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
OCREVUS |
drug |
$15,089 |
NO PRODUCT DISCUSSED |
drug |
$11,984 |
Payments with no listed product |
N/A |
$9,442 |
OMB157A |
drug |
$6,541 |
GILENYA |
drug |
$1,567 |
OMB157B |
drug |
$1,384 |
REBIF |
drug |
$24 |
TECFIDERA |
drug |
$21 |
TYSABRI |
drug |
$21 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Nov 30, 2018 | $11,172 | NO PRODUCT DISCUSSED | Consulting | GENZYME CORPORATION | |
May 4, 2018 | $7,700 | OCREVUS | Consulting | GENENTECH, INC. | |
Dec 8, 2018 | $6,742 | No Listed Product | Consulting | NOVARTIS PHARMACEUTICALS CORPORATION | |
Jun 19, 2018 | $6,466 | OMB157A | Consulting | NOVARTIS PHARMA AG | |
Jun 30, 2018 | $2,152 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Aug 21, 2018 | $1,914 | No Listed Product | Consulting | NOVARTIS PHARMACEUTICALS CORPORATION | |
Nov 6, 2018 | $1,800 | OCREVUS | Consulting | GENENTECH, INC. | |
Jan 24, 2018 | $1,276 | GILENYA | Consulting | NOVARTIS PHARMACEUTICALS CORPORATION | |
Sep 30, 2018 | $1,118 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Mar 31, 2018 | $994 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
May 4, 2018 | $553 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
May 4, 2018 | $517 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
Apr 13, 2018 | $441 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Apr 15, 2018 | $331 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Nov 30, 2018 | $324 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
Apr 14, 2018 | $249 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Apr 13, 2018 | $206 | OMB157B | Food and Beverage | NOVARTIS PHARMA AG | |
May 5, 2018 | $205 | OCREVUS | Food and Beverage | GENENTECH, INC. | |
Dec 8, 2018 | $175 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Nov 30, 2018 | $164 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
Dec 8, 2018 | $143 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Nov 30, 2018 | $122 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
Feb 13, 2018 | $116 | GILENYA | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Dec 8, 2018 | $108 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Apr 25, 2018 | $102 | No Listed Product | Food and Beverage | GENENTECH USA, INC. | |
May 2, 2018 | $98 | GILENYA | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Sep 25, 2018 | $76 | GILENYA | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
May 31, 2018 | $72 | No Listed Product | Food and Beverage | BIOGEN, INC. | |
Jan 8, 2018 | $70 | No Listed Product | Food and Beverage | BIOGEN, INC. | |
Nov 30, 2018 | $61 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
Apr 13, 2018 | $52 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Apr 13, 2018 | $52 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Apr 14, 2018 | $52 | OMB157B | Travel and Lodging | NOVARTIS PHARMA AG | |
Nov 30, 2018 | $43 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
Nov 30, 2018 | $43 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
Oct 12, 2018 | $40 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Jun 19, 2018 | $39 | OMB157A | Food and Beverage | NOVARTIS PHARMA AG | |
Jun 19, 2018 | $36 | OMB157A | Travel and Lodging | NOVARTIS PHARMA AG | |
Nov 30, 2018 | $35 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
May 4, 2018 | $32 | OCREVUS | Food and Beverage | GENENTECH, INC. | |
Dec 8, 2018 | $26 | No Listed Product | Travel and Lodging | NOVARTIS PHARMACEUTICALS CORPORATION | |
Dec 7, 2018 | $22 | No Listed Product | Food and Beverage | NOVARTIS PHARMACEUTICALS CORPORATION | |
Feb 6, 2018 | $21 | TYSABRI TECFIDERA | Food and Beverage | BIOGEN, INC. | |
Jul 18, 2018 | $20 | No Listed Product | Food and Beverage | BIOGEN, INC. | |
May 4, 2018 | $18 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
Nov 30, 2018 | $18 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
Aug 17, 2018 | $8 | REBIF | Food and Beverage | EMD SERONO, INC. | |
Jun 12, 2018 | $8 | REBIF | Food and Beverage | EMD SERONO, INC. | |
Aug 29, 2018 | $8 | REBIF | Food and Beverage | EMD SERONO, INC. | |
May 31, 2018 | $8 | No Listed Product | Food and Beverage | BIOGEN, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.